Andrew P May

researcher (ORCID 0000-0003-3567-3435)

Andrew P May is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-3567-3435

P734family nameMayQ1751954
MayQ1751954
MayQ1751954
P735given nameAndrewQ18042461
AndrewQ18042461
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q27674473A Structural Basis for the Assembly and Functions of a Viral Polymer that Inactivates Multiple Tumor Suppressors
Q27663749A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function
Q112569177A functional map of HIV-host interactions in primary human T cells
Q64115437A large CRISPR-induced bystander mutation causes immune dysregulation
Q44874376Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Q43806776Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.
Q45255570Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering
Q28215051Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle
Q34408515Crystal structure and mechanism of the Escherichia coli ArnA (PmrI) transformylase domain. An enzyme for lipid A modification with 4-amino-4-deoxy-L-arabinose and polymyxin resistance
Q24646087Crystal structure of Escherichia coli ArnA (PmrI) decarboxylase domain. A key enzyme for lipid A modification with 4-amino-4-deoxy-L-arabinose and polymyxin resistance
Q28276521Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin
Q49131954DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks
Q44957387Efficient macromolecular crystallization using microfluidics and randomized design of screening reagents
Q91378977Fast-Seq, a simple method for rapid and inexpensive validation of packaged ssAAV genomes in academic settings
Q92114827Fast-Seq: A Simple Method for Rapid and Inexpensive Validation of Packaged Single-Stranded Adeno-Associated Viral Genomes in Academic Settings
Q44876033Guide RNA functional modules direct Cas9 activity and orthogonality
Q91330227Harnessing type I CRISPR-Cas systems for genome engineering in human cells
Q92267542Large dataset enables prediction of repair after CRISPR-Cas9 editing in primary T cells
Q34315297Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex
Q27677863Macro-to-Micro Structural Proteomics: Native Source Proteins for High-Throughput Crystallization
Q46120380Mapping the genomic landscape of CRISPR-Cas9 cleavage.
Q100387393Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct Vectors
Q34278191Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.
Q33975855Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
Q57555848Reprogramming human T cell function and specificity with non-viral genome targeting
Q57555850Reprogramming human T cell function and specificity with non-viral genome targeting
Q35185544Single-cell RNA-seq reveals dynamic paracrine control of cellular variation
Q24630632Structure and mechanism of ArnA: conformational change implies ordered dehydrogenase mechanism in key enzyme for polymyxin resistance
Q37808166The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication
Q43847607Uncoupling the ATPase activity of the N-ethylmaleimide sensitive factor (NSF) from 20S complex disassembly
Q44876995Unraveling the potential of CRISPR-Cas9 for gene therapy

Search more.